StockData
Pluri Inc. logo

Pluri Inc. (PLUR) stock

PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.98−0.06 (-5.77%)

Close on Nov 17, 2026Market cap $12.10MP/E –Yield –

Pluri price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Pluri's price to sales ratio was 12.8× on Nov 11, 2026, against 23.2× a year earlier. Over the last 5 years it ranged from 10.7× to 236.1×, with a median of 45.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202612.8×−5.6
2025Dec 31, 202518.4×−21.0
2024Dec 31, 202439.4×−55.2
2023Dec 29, 202394.6×−2.7
2022Oct 31, 202297.2×+53.5
2016Oct 31, 201643.7×−192.4
2015Dec 31, 2015236.1×−222.9
2014Dec 31, 2014459.0×+95.1
2013Dec 31, 2013363.9×+16.8
2012Dec 31, 2012347.1×–

More Pluri figures

See a number that looks wrong?